Department of Biomedical Sciences and Engineering, College of Health Sciences and Technology, National Central University, Taoyuan, Taiwan.
Genomics Research Center, Academia Sinica, Taipei, Taiwan.
J Invest Dermatol. 2018 Apr;138(4):911-921. doi: 10.1016/j.jid.2017.11.016. Epub 2017 Nov 26.
Tumors grow because cancer cells lack the ability to balance cell survival and death signaling pathways. miR-596, a microRNA located at the 8p23.3 locus, has been shown by the TCGA-Assembler to be deleted in a significant number of melanoma samples. Here, we also validated the low levels of miR-596 in melanoma compared to tissue nevi, and Kaplan-Meier curve analysis revealed that low miR-596 expression was associated with worse overall survival. Moreover, we showed that miR-596 overexpression effectively inhibited MAPK/ERK signaling, cell proliferation, migration, and invasion and increased the cell apoptosis of melanoma cells. In addition, we found that miR-596 directly targets MEK1 and two apoptotic proteins, MCL1, and BCL2L1, in melanoma cells. Our findings indicated that miR-596 is an important miRNA that both negatively regulates the MAPK/ERK signaling pathway by targeting MEK1 and modulates the apoptosis pathway by targeting MCL1 and BCL2L1, suggesting that miR-596 could be a therapeutic candidate for treating melanoma, and a prognostic factor for melanoma patients.
肿瘤之所以生长,是因为癌细胞缺乏平衡细胞存活和死亡信号通路的能力。miR-596 是位于 8p23.3 位置的 microRNA,TCGA-Assembler 已经证实其在大量黑色素瘤样本中缺失。在这里,我们还验证了与组织痣相比,黑色素瘤中 miR-596 的水平较低,Kaplan-Meier 曲线分析表明低表达 miR-596 与总生存期较差相关。此外,我们表明 miR-596 的过表达有效地抑制了 MAPK/ERK 信号、细胞增殖、迁移和侵袭,并增加了黑色素瘤细胞的细胞凋亡。此外,我们发现 miR-596 在黑色素瘤细胞中直接靶向 MEK1 和两种凋亡蛋白 MCL1 和 BCL2L1。我们的研究结果表明,miR-596 是一种重要的 miRNA,通过靶向 MEK1 负调控 MAPK/ERK 信号通路,并通过靶向 MCL1 和 BCL2L1 调节凋亡通路,表明 miR-596 可能成为治疗黑色素瘤的治疗候选物,也是黑色素瘤患者的预后因素。